Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin + Lenalidomide + Dexamethasone vs Lenalidomide + Dexamethasone in Newly Diagnosed MM
NCT02575144Phase 3Unknown
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2015
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin in multiple myeloma (MM), sponsored by Fundación PETHEMA. Status: unknown.
02
Drugs
clarithromycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02575144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575144.